CANNABINOIDS have been found to be effective against some types of breast cancer (BC) in recent studies, according to an ASX update from Zelda Therapeutics.
It appears from the studies that the products may be beneficial across a broad spectrum of breast cancer types including hormone receptor positive, HER2+ and the very difficult-to-treat Triple Negative cancer types, Zelda said.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jun 17